Your browser doesn't support javascript.
loading
Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma.
Watson, Leisa R; Lew, Thomas E; Fox, Lucy C; Khot, Amit; van der Weyden, Carrie.
Affiliation
  • Watson LR; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
  • Lew TE; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
  • Fox LC; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
  • Khot A; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
  • van der Weyden C; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia.
Leuk Lymphoma ; 63(13): 3217-3221, 2022 12.
Article in En | MEDLINE | ID: mdl-36070587
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Panniculitis / Lymphoma, T-Cell / Lymphoma, T-Cell, Cutaneous / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Panniculitis / Lymphoma, T-Cell / Lymphoma, T-Cell, Cutaneous / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Australia